Nautilus Biotechnology Unveils Voyager Proteomics Platform, Targets Beta Access in 2H and Launch Next Year [Yahoo! Finance]
Nautilus Biotechnology, Inc. (NAUT)
Company Research
Source: Yahoo! Finance
next year, is expected to be priced at roughly $1 million , run 4/8/12 samples per day, and depend on per-sample consumables likely costing a few thousand dollars with an internal long-term consumable pull-through target of about $500,000 per instrument per year The company's core method, called iterative mapping , uses a chip that immobilizes " 10 billion protein molecules ", a new class of antibodies, and analytics to deliver single-molecule proteomics and targeted proteoform assays — Nautilus already offers a tau assay measuring 768 different forms and plans oncology and alpha-synuclein assays in early access. Nautilus reported $156 million in cash and says runway extends through 2027 , positioning it to pursue a proteomics market it estimates could reach $57 billion by 2030 Interested in Nautilus Biotechnology, Inc.? Here are five stocks we like better. Nautilus Biotechnology (NASDAQ:NAUT) executives outlined the company's strategy to “unlock the power of the proteome” and
Show less
Read more
Impact Snapshot
Event Time:
NAUT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NAUT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NAUT alerts
High impacting Nautilus Biotechnology, Inc. news events
Weekly update
A roundup of the hottest topics
NAUT
News
- Nautilus Biotechnology to Participate in the Investor Summit Group Virtual ConferenceGlobeNewswire
- Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform [Yahoo! Finance]Yahoo! Finance
- Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager PlatformGlobeNewswire
- Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of SalesGlobeNewswire
- Nautilus Biotechnology (NAUT) had its price target raised by Guggenheim from $2.50 to $4.00. They now have a "buy" rating on the stock.MarketBeat
NAUT
Earnings
- 4/29/25 - Beat
NAUT
Sec Filings
- 3/4/26 - Form SCHEDULE
- 3/4/26 - Form SCHEDULE
- 3/4/26 - Form 4
- NAUT's page on the SEC website